therapeutic antibody fragments (Cell Medica)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Nametherapeutic antibody fragments (Cell Medica)
Drug Alias NameDLX-903
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragment
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCell Medica Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCell Medica Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A